Clinical trials show average weight loss of 10 to 15 percent of body weight over 68 weeks at the full 2.4 mg dose (per the STEP 1 trial published in the New England Journal of Medicine, 2021)
[164] [165] In July 2023, the Icelandic Medicines Agency reported two cases of suicidal thoughts and one case of self-injury of users of the injection, prompting a safety assessment of Ozempic, [166] Wegovy, Saxenda, and similar drugs
Aesthetic Surgery Journal Open Forum .
Novo Nordisk's semaglutide is produced at scale via a hybrid biological-chemical process 1 , while Eli Lillys tirzepatide is chemically synthesized 2
GLP-1 receptor activation The GLP-1 component of retatrutide reduces appetite through multiple mechanisms: slowing gastric emptying (food stays in your stomach longer, so you feel full sooner), signaling satiety centers in the brain (your brain gets a stronger "stop eating" signal), and enhancing insulin secretion in response to meals